Posted in | News | Nanomaterials

NanoViricides to Expand Production of Drug Candidates for Toxicological Studies

NanoViricides declared that it will lease a new area for producing nanoviricides drug candidates to fight several viral diseases. The company plans to lease the area presently and may purchase the same later from Inno-Haven if required.

Inno-Haven is a special purpose company that was formed to acquire a facility and construct needed manufacturing and laboratory infrastructure.

NanoViricides has to manufacture huge quantities of drug candidates for its forthcoming toxicological studies than it can manage using the current facilities.

Additional materials will have to be produced for performing human clinical trials with the approval of the US Food and Drug Administration (FDA). The materials required for human trials need to be manufactured under a set of guidelines by FDA called “current Good Manufacturing Practices” (cGMP). At the new facility, the company hopes to produce the bulk cGMP drug materials. In order to meet the objectives of NanoViricides, Inno-Haven has agreed to buy certain facilities and provide it on lease to NanoViricides.

The company believes that it is in urgent need for setting up these manufacturing capabilities with the success of its FluCide drug candidates for performing pre-clinical animal studies.

Source: http://www.nanoviricides.com/

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    NanoViricides, Inc. (2019, February 12). NanoViricides to Expand Production of Drug Candidates for Toxicological Studies. AZoNano. Retrieved on May 18, 2024 from https://www.azonano.com/news.aspx?newsID=22748.

  • MLA

    NanoViricides, Inc. "NanoViricides to Expand Production of Drug Candidates for Toxicological Studies". AZoNano. 18 May 2024. <https://www.azonano.com/news.aspx?newsID=22748>.

  • Chicago

    NanoViricides, Inc. "NanoViricides to Expand Production of Drug Candidates for Toxicological Studies". AZoNano. https://www.azonano.com/news.aspx?newsID=22748. (accessed May 18, 2024).

  • Harvard

    NanoViricides, Inc. 2019. NanoViricides to Expand Production of Drug Candidates for Toxicological Studies. AZoNano, viewed 18 May 2024, https://www.azonano.com/news.aspx?newsID=22748.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.